|
Avastin
Bevacizumab
- Strength / route
- 100mg/4ml · Infusion
- Qty
- 390 Vial
- Total
- 2,649,819,510
- Group
- N1
- Manufacturer
- Roche Diagnostics GmbH (Germany)
- Province / Facility
- Ho Chi Minh City · 79048
|
400410250123 |
100mg/4ml
Infusion
|
Vial |
390
|
6,794,409
|
2,649,819,510
|
N1 |
Roche Diagnostics GmbH
Germany
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Avastin
Bevacizumab
- Strength / route
- 100mg/4ml · Infusion
- Qty
- 661 Vial
- Total
- 4,491,104,349
- Group
- N1
- Manufacturer
- Roche Diagnostics GmbH (Germany)
- Province / Facility
- Da Nang · 48126
|
400410250123 |
100mg/4ml
Infusion
|
Vial |
661
|
6,794,409
|
4,491,104,349
|
N1 |
Roche Diagnostics GmbH
Germany
|
Da Nang
48126
|
2026-04-14 |
|
Avastin
Bevacizumab
- Strength / route
- 400mg/ 16ml · Infusion
- Qty
- 791 Vial
- Total
- 19,631,295,075
- Group
- N1
- Manufacturer
- Roche Diagnostics GmbH (Germany)
- Province / Facility
- Da Nang · 48126
|
400410250223 |
400mg/ 16ml
Infusion
|
Vial |
791
|
24,818,325
|
19,631,295,075
|
N1 |
Roche Diagnostics GmbH
Germany
|
Da Nang
48126
|
2026-04-14 |
|
Avelox
Moxifloxacin
- Strength / route
- 400mg/250ml · Intravenous infusion
- Qty
- 1,718 Chai
- Total
- 631,365,000
- Group
- N1
- Manufacturer
- Bulk product manufacturing, primary and secondary packaging site: Fresenius Kabi Italia S.R.L; Batch release site: Bayer AG (Bulk product manufacturing, primary and secondary packaging site: Italy; Batch release site: Germany)
- Province / Facility
- Ho Chi Minh City · 79048
|
800115961124 |
400mg/250ml
Intravenous infusion
|
Chai |
1,718
|
367,500
|
631,365,000
|
N1 |
Bulk product manufacturing, primary and secondary packaging site: Fresenius Kabi Italia S.R.L; Batch release site: Bayer AG
Bulk product manufacturing, primary and secondary packaging site: Italy; Batch release site: Germany
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Avodart
Dutasterid
- Strength / route
- 0,5mg · Oral
- Qty
- 47,138 Tablet
- Total
- 813,460,466
- Group
- N1
- Manufacturer
- Delpharm Poznań S.A. (Ba Lan)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-17445-13 |
0,5mg
Oral
|
Tablet |
47,138
|
17,257
|
813,460,466
|
N1 |
Delpharm Poznań S.A.
Ba Lan
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Azopt
Brinzolamid
- Strength / route
- 10mg/ml · Ophthalmic
- Qty
- 520 Vial
- Total
- 60,683,480
- Group
- N1
- Manufacturer
- Alcon Research, LLC (United States)
- Province / Facility
- Ho Chi Minh City · 79048
|
001110009924 |
10mg/ml
Ophthalmic
|
Vial |
520
|
116,699
|
60,683,480
|
N1 |
Alcon Research, LLC
United States
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
BESTANE
Exemestan
- Strength / route
- 25mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N2
- Manufacturer
- Sun Pharmaceutical Industries Ltd (India)
- Province / Facility
- Hanoi · 01816
|
VN3-344-21 |
25mg
Oral
|
Tablet |
0
|
25,800
|
0
|
N2 |
Sun Pharmaceutical Industries Ltd
India
|
Hanoi
01816
|
2026-04-14 |
|
BESTANE
Exemestan
- Strength / route
- 25mg · Oral
- Qty
- 3,000 Tablet
- Total
- 77,400,000
- Group
- N2
- Manufacturer
- Sun Pharmaceutical Industries Ltd (India)
- Province / Facility
- Hanoi · 01816
|
890114040725 |
25mg
Oral
|
Tablet |
3,000
|
25,800
|
77,400,000
|
N2 |
Sun Pharmaceutical Industries Ltd
India
|
Hanoi
01816
|
2026-04-14 |
|
BFS-Nabica 8,4%
Natri hydrocarbonat (natri bicarbonat)
- Strength / route
- 840 mg/ 10 ml · Injection
- Qty
- 1,300 Vial
- Total
- 25,662,000
- Group
- N4
- Manufacturer
- CPC1 Hanoi Pharmaceutical JSC (Vietnam)
- Province / Facility
- Ba Ria – Vung Tau · 77001
|
VD-26123-17 |
840 mg/ 10 ml
Injection
|
Vial |
1,300
|
19,740
|
25,662,000
|
N4 |
CPC1 Hanoi Pharmaceutical JSC
Vietnam
|
Ba Ria – Vung Tau
77001
|
2026-04-14 |
|
Basicillin 100mg
Doxycyclin (as Doxycyclin hyclat)
- Strength / route
- 100mg · Oral
- Qty
- 4,000 Tablet
- Total
- 7,560,000
- Group
- N1
- Manufacturer
- Contract manufacturer: Medochemie (Far East) Co., Ltd. (Vietnam)
- Province / Facility
- Ha Giang · 02001
|
893610332524 |
100mg
Oral
|
Tablet |
4,000
|
1,890
|
7,560,000
|
N1 |
Contract manufacturer: Medochemie (Far East) Co., Ltd.
Vietnam
|
Ha Giang
02001
|
2026-04-14 |
|
Basicillin 100mg
Doxycyclin (as Doxycyclin hyclat)
- Strength / route
- 100mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- Contract manufacturer: Medochemie (Far East) Co., Ltd. (Vietnam)
- Province / Facility
- Ha Giang · 02001
|
GC-310-18 |
100mg
Oral
|
Tablet |
0
|
1,890
|
0
|
N1 |
Contract manufacturer: Medochemie (Far East) Co., Ltd.
Vietnam
|
Ha Giang
02001
|
2026-04-14 |
|
Becolugel-S
magnesium hydroxyd + nhom hydroxyd + simethicon
- Strength / route
- 800mg+800,4mg+0,08g · Oral
- Qty
- 30,000 Sachet
- Total
- 114,000,000
- Group
- N4
- Manufacturer
- Ben Tre Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01816
|
893100536024 |
800mg+800,4mg+0,08g
Oral
|
Sachet |
30,000
|
3,800
|
114,000,000
|
N4 |
Ben Tre Pharmaceutical JSC
Vietnam
|
Hanoi
01816
|
2026-04-14 |
|
Becolugel-S
magnesium hydroxyd + nhom hydroxyd + simethicon
- Strength / route
- 800mg+800,4mg+0,08g · Oral
- Qty
- 0 Sachet
- Total
- 0
- Group
- N4
- Manufacturer
- Ben Tre Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01816
|
VD3-103-21 |
800mg+800,4mg+0,08g
Oral
|
Sachet |
0
|
3,800
|
0
|
N4 |
Ben Tre Pharmaceutical JSC
Vietnam
|
Hanoi
01816
|
2026-04-14 |
|
Betaloc Zok 25mg
Metoprolol
- Strength / route
- 23,75mg · Oral
- Qty
- 1,367,600 Tablet
- Total
- 6,002,396,400
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-17243-13 |
23,75mg
Oral
|
Tablet |
1,367,600
|
4,389
|
6,002,396,400
|
N1 |
AstraZeneca AB
Sweden
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Betaloc Zok 25mg
Metoprolol
- Strength / route
- 23,75mg · Oral
- Qty
- 158 Tablet
- Total
- 693,462
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Da Nang · 48126
|
VN-17243-13 |
23,75mg
Oral
|
Tablet |
158
|
4,389
|
693,462
|
N1 |
AstraZeneca AB
Sweden
|
Da Nang
48126
|
2026-04-14 |
|
Betaloc Zok 50mg
Metoprolol
- Strength / route
- 47.5mg (equivalent to 50mg metoprolol tartrate or 39mg metoprolol) · Oral
- Qty
- 2,940,600 Tablet
- Total
- 16,143,894,000
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Ho Chi Minh City · 79048
|
730110022123 |
47.5mg (equivalent to 50mg metoprolol tartrate or 39mg metoprolol)
Oral
|
Tablet |
2,940,600
|
5,490
|
16,143,894,000
|
N1 |
AstraZeneca AB
Sweden
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Betaserc 24mg
Betahistin
- Strength / route
- 24mg · Oral
- Qty
- 209,040 Tablet
- Total
- 1,362,104,640
- Group
- N1
- Manufacturer
- Mylan Laboratories S.A.S (France)
- Province / Facility
- Ho Chi Minh City · 79048
|
300110779724 |
24mg
Oral
|
Tablet |
209,040
|
6,516
|
1,362,104,640
|
N1 |
Mylan Laboratories S.A.S
France
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Bilaxten (cơ sở kiểm nghiệm: A. Menarini Manufacturing Logistics and Services S.r.l.; địa chỉ: Via Sette Santi, 3 - 50131 Firenze (FI), Italy)
Bilastine
- Strength / route
- 20mg · Oral
- Qty
- 16,562 Tablet
- Total
- 154,026,600
- Group
- N1
- Manufacturer
- A. Menarini Manufacturing Logistics and Services S.r.l (Italy)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN2-496-16 |
20mg
Oral
|
Tablet |
16,562
|
9,300
|
154,026,600
|
N1 |
A. Menarini Manufacturing Logistics and Services S.r.l
Italy
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Bixebra 7.5 mg
Ivabradin
- Strength / route
- 7,5mg · Oral
- Qty
- 15,000 Tablet
- Total
- 142,500,000
- Group
- N1
- Manufacturer
- KRKA, d.d., Novo Mesto (Slovenia)
- Province / Facility
- Hai Duong · 30001
|
VN-22878-21 |
7,5mg
Oral
|
Tablet |
15,000
|
9,500
|
142,500,000
|
N1 |
KRKA, d.d., Novo Mesto
Slovenia
|
Hai Duong
30001
|
2026-04-14 |
|
Brilinta
Ticagrelor
- Strength / route
- 60mg · Oral
- Qty
- 207,727 Tablet
- Total
- 3,297,250,671
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-23103-22 |
60mg
Oral
|
Tablet |
207,727
|
15,873
|
3,297,250,671
|
N1 |
AstraZeneca AB
Sweden
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Brilinta
Ticagrelor
- Strength / route
- 90mg · Oral
- Qty
- 650,000 Tablet
- Total
- 10,317,450,000
- Group
- N1
- Manufacturer
- AstraZeneca AB (Sweden)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-19006-15 |
90mg
Oral
|
Tablet |
650,000
|
15,873
|
10,317,450,000
|
N1 |
AstraZeneca AB
Sweden
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Broncho-vaxom Adults
Chat ly giai vi khuan dong kho of Haemophilus influenzae + Diplococcus pneumoniae + Klebsiella pneumoniae and ozaenae + Staphylococcus aureus + Streptococcus pyogenes and viridans + Neisseria catarrhalis
- Strength / route
- 7mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- OM Pharma SA (Switzerland)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-18753-15 |
7mg
Oral
|
Tablet |
0
|
19,530
|
0
|
N1 |
OM Pharma SA
Switzerland
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Broncho-vaxom Adults
Chat ly giai vi khuan dong kho of Haemophilus influenzae + Diplococcus pneumoniae + Klebsiella pneumoniae and ozaenae + Staphylococcus aureus + Streptococcus pyogenes and viridans + Neisseria catarrhalis
- Strength / route
- 7mg · Oral
- Qty
- 19,994 Tablet
- Total
- 390,482,820
- Group
- N1
- Manufacturer
- OM Pharma SA (Switzerland)
- Province / Facility
- Ho Chi Minh City · 79048
|
760410178300 |
7mg
Oral
|
Tablet |
19,994
|
19,530
|
390,482,820
|
N1 |
OM Pharma SA
Switzerland
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Broncho-vaxom Adults
Chat ly giai vi khuan dong kho of Haemophilus influenzae + Diplococcus pneumoniae + Klebsiella pneumoniae and ozaenae + Staphylococcus aureus + Streptococcus pyogenes and viridans + Neisseria catarrhalis
- Strength / route
- 7mg · Oral
- Qty
- 0 Tablet
- Total
- 0
- Group
- N1
- Manufacturer
- OM Pharma SA (Switzerland)
- Province / Facility
- Ho Chi Minh City · 79048
|
QLSP-1115-18 |
7mg
Oral
|
Tablet |
0
|
19,530
|
0
|
N1 |
OM Pharma SA
Switzerland
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Cammic
Acid tranexamic
- Strength / route
- 250 mg/5ml · Injection
- Qty
- 2,500 Ampoule
- Total
- 2,700,000
- Group
- N4
- Manufacturer
- Vinh Phuc Pharmaceutical JSC (Vietnam)
- Province / Facility
- Bac Ninh · 27002
|
893110306123 |
250 mg/5ml
Injection
|
Ampoule |
2,500
|
1,080
|
2,700,000
|
N4 |
Vinh Phuc Pharmaceutical JSC
Vietnam
|
Bac Ninh
27002
|
2026-04-14 |
|
Cammic
Tranexamic acid
- Strength / route
- 250mg/5ml · Injection
- Qty
- 4,000 Ampoule
- Total
- 4,320,000
- Group
- N4
- Manufacturer
- Vinh Phuc Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01160
|
893110306123 |
250mg/5ml
Injection
|
Ampoule |
4,000
|
1,080
|
4,320,000
|
N4 |
Vinh Phuc Pharmaceutical JSC
Vietnam
|
Hanoi
01160
|
2026-04-14 |
|
Campto
Irinotecan
- Strength / route
- 40mg/2ml · Intravenous infusion
- Qty
- 4,000 Vial
- Total
- 5,297,796,000
- Group
- N1
- Manufacturer
- Bridgewest Perth Pharma Pty Ltd (Australia)
- Province / Facility
- Ho Chi Minh City · 79048
|
930114207623 |
40mg/2ml
Intravenous infusion
|
Vial |
4,000
|
1,324,449
|
5,297,796,000
|
N1 |
Bridgewest Perth Pharma Pty Ltd
Australia
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Campto
Irinotecan
- Strength / route
- 40mg/2ml · Injection
- Qty
- 221 Vial
- Total
- 292,703,229
- Group
- N1
- Manufacturer
- Bridgewest Perth Pharma Pty Ltd (Australia)
- Province / Facility
- Da Nang · 48126
|
930114207623 |
40mg/2ml
Injection
|
Vial |
221
|
1,324,449
|
292,703,229
|
N1 |
Bridgewest Perth Pharma Pty Ltd
Australia
|
Da Nang
48126
|
2026-04-14 |
|
Cancidas
Caspofungin*
- Strength / route
- 50mg · Intravenous infusion
- Qty
- 5,850 Vial
- Total
- 38,206,350,000
- Group
- N1
- Manufacturer
- FAREVA Mirabel (France)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-20811-17 |
50mg
Intravenous infusion
|
Vial |
5,850
|
6,531,000
|
38,206,350,000
|
N1 |
FAREVA Mirabel
France
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Cancidas
Caspofungin*
- Strength / route
- 70mg · Intravenous infusion
- Qty
- 609 Vial
- Total
- 5,047,818,300
- Group
- N1
- Manufacturer
- FAREVA Mirabel (France)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-20568-17 |
70mg
Intravenous infusion
|
Vial |
609
|
8,288,700
|
5,047,818,300
|
N1 |
FAREVA Mirabel
France
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Cancidas
Caspofungin*
- Strength / route
- 50mg · Intravenous infusion
- Qty
- 2,400 Vial
- Total
- 15,674,400,000
- Group
- N1
- Manufacturer
- FAREVA Mirabel (France)
- Province / Facility
- Hanoi · 01920
|
VN-20811-17 |
50mg
Intravenous infusion
|
Vial |
2,400
|
6,531,000
|
15,674,400,000
|
N1 |
FAREVA Mirabel
France
|
Hanoi
01920
|
2026-04-14 |
|
Cancidas
Caspofungin*
- Strength / route
- 70mg · Intravenous infusion
- Qty
- 280 Vial
- Total
- 2,320,836,000
- Group
- N1
- Manufacturer
- FAREVA Mirabel (France)
- Province / Facility
- Hanoi · 01920
|
VN-20568-17 |
70mg
Intravenous infusion
|
Vial |
280
|
8,288,700
|
2,320,836,000
|
N1 |
FAREVA Mirabel
France
|
Hanoi
01920
|
2026-04-14 |
|
Candekern 8mg Tablet
Candesartan cilexetil 8mg
- Strength / route
- 8mg · Oral
- Qty
- 50,000 Tablet
- Total
- 225,000,000
- Group
- N1
- Manufacturer
- Kern Pharma S.L. (Spain)
- Province / Facility
- Thanh Hoa · 38010
|
840110007824 |
8mg
Oral
|
Tablet |
50,000
|
4,500
|
225,000,000
|
N1 |
Kern Pharma S.L.
Spain
|
Thanh Hoa
38010
|
2026-04-14 |
|
Casodex
Bicalutamid
- Strength / route
- 50mg · Oral
- Qty
- 27,300 Tablet
- Total
- 3,115,694,400
- Group
- N1
- Manufacturer
- Manufacturing site: Corden Pharma GmbH; Packaging site: AstraZeneca UK Limited (Country of manufacture: Germany; Country of packaging: United Kingdom)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-18149-14 |
50mg
Oral
|
Tablet |
27,300
|
114,128
|
3,115,694,400
|
N1 |
Manufacturing site: Corden Pharma GmbH; Packaging site: AstraZeneca UK Limited
Country of manufacture: Germany; Country of packaging: United Kingdom
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Cebest
Cefpodoxime (as Cefpodoxime proxetil)
- Strength / route
- 50mg/1,5g · Oral
- Qty
- 10,000 Sachet
- Total
- 60,000,000
- Group
- N3
- Manufacturer
- Merap Group JSC (Vietnam)
- Province / Facility
- Bac Ninh · 27002
|
893110151925 |
50mg/1,5g
Oral
|
Sachet |
10,000
|
6,000
|
60,000,000
|
N3 |
Merap Group JSC
Vietnam
|
Bac Ninh
27002
|
2026-04-14 |
|
Cefaclor 125mg
Cefaclor
- Strength / route
- 125mg · Oral
- Qty
- 40,000 Sachet
- Total
- 51,200,000
- Group
- N4
- Manufacturer
- Minh Dan Pharmaceutical JSC (Vietnam)
- Province / Facility
- Nghe An · 40018
|
893110137625 |
125mg
Oral
|
Sachet |
40,000
|
1,280
|
51,200,000
|
N4 |
Minh Dan Pharmaceutical JSC
Vietnam
|
Nghe An
40018
|
2026-04-14 |
|
Ceftizoxim 1g
Ceftizoxim
- Strength / route
- 1g · Injection
- Qty
- 20,000 Vial
- Total
- 1,300,000,000
- Group
- N2
- Manufacturer
- Imexpharm Corporation – Branch 3 in Binh Duong (Vietnam)
- Province / Facility
- Hai Phong · 31010
|
893110252523 |
1g
Injection
|
Vial |
20,000
|
65,000
|
1,300,000,000
|
N2 |
Imexpharm Corporation – Branch 3 in Binh Duong
Vietnam
|
Hai Phong
31010
|
2026-04-14 |
|
Celebrex
Celecoxib
- Strength / route
- 200mg · Oral
- Qty
- 130,000 Tablet
- Total
- 1,548,690,000
- Group
- N1
- Manufacturer
- Viatris Pharmaceuticals LLC; Packaging and batch release: Pfizer Manufacturing Deutschland GmbH (Manufacturing site: United States, Packaging and batch release: Germany)
- Province / Facility
- Ho Chi Minh City · 79048
|
VN-23247-22 |
200mg
Oral
|
Tablet |
130,000
|
11,913
|
1,548,690,000
|
N1 |
Viatris Pharmaceuticals LLC; Packaging and batch release: Pfizer Manufacturing Deutschland GmbH
Manufacturing site: United States, Packaging and batch release: Germany
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Cellcept
Mycophenolat
- Strength / route
- 250mg · Oral
- Qty
- 1,988,818 Tablet
- Total
- 47,053,445,062
- Group
- N1
- Manufacturer
- Manufacturing and packaging site: Delpharm Milano S.r.l; Batch release site: F. Hoffmann – La Roche AG (Manufacturing and packaging site: Italy; Batch release site: Switzerland)
- Province / Facility
- Ho Chi Minh City · 79048
|
800114432423 |
250mg
Oral
|
Tablet |
1,988,818
|
23,659
|
47,053,445,062
|
N1 |
Manufacturing and packaging site: Delpharm Milano S.r.l; Batch release site: F. Hoffmann – La Roche AG
Manufacturing and packaging site: Italy; Batch release site: Switzerland
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Cephalexin
Cephalexin
- Strength / route
- 500mg · Oral
- Qty
- 3,000 Tablet
- Total
- 2,460,000
- Group
- N4
- Manufacturer
- Minh Dan Pharmaceutical JSC (Vietnam)
- Province / Facility
- Ninh Binh · 37315
|
893110065224 |
500mg
Oral
|
Tablet |
3,000
|
820
|
2,460,000
|
N4 |
Minh Dan Pharmaceutical JSC
Vietnam
|
Ninh Binh
37315
|
2026-04-14 |
|
Cephalexin
Cephalexin
- Strength / route
- 500mg · Oral
- Qty
- 2,000 Tablet
- Total
- 1,640,000
- Group
- N4
- Manufacturer
- Minh Dan Pharmaceutical JSC (Vietnam)
- Province / Facility
- Ninh Binh · 37313
|
893110065224 |
500mg
Oral
|
Tablet |
2,000
|
820
|
1,640,000
|
N4 |
Minh Dan Pharmaceutical JSC
Vietnam
|
Ninh Binh
37313
|
2026-04-14 |
|
Cephalexin
Cephalexin
- Strength / route
- 500mg · Oral
- Qty
- 2,000 Tablet
- Total
- 1,640,000
- Group
- N4
- Manufacturer
- Minh Dan Pharmaceutical JSC (Vietnam)
- Province / Facility
- Ninh Binh · 37021
|
893110065224 |
500mg
Oral
|
Tablet |
2,000
|
820
|
1,640,000
|
N4 |
Minh Dan Pharmaceutical JSC
Vietnam
|
Ninh Binh
37021
|
2026-04-14 |
|
Cerebrolysin
Peptid (Cerebrolysin concentrate)
- Strength / route
- 2,152g/10ml · Injection
- Qty
- 31,324 Ampoule
- Total
- 3,437,025,900
- Group
- N1
- Manufacturer
- Batch release site: EVER NEURO PHARMA GmbH (Blending and packaging site: Ever Pharma Jena GmbH - Germany) (Austria)
- Province / Facility
- Ho Chi Minh City · 79048
|
QLSP-845-15 |
2,152g/10ml
Injection
|
Ampoule |
31,324
|
109,725
|
3,437,025,900
|
N1 |
Batch release site: EVER NEURO PHARMA GmbH (Blending and packaging site: Ever Pharma Jena GmbH - Germany)
Austria
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Cerebrolysin
Peptid (Cerebrolysin concentrate)
- Strength / route
- 215,2mg/ml, 10ml · Injection
- Qty
- 1,000 Ampoule
- Total
- 109,725,000
- Group
- N1
- Manufacturer
- Batch release site: Ever Neuro Pharma GmbH (Batch release site: Austria)
- Province / Facility
- Nghe An · 40018
|
QLSP-845-15 |
215,2mg/ml, 10ml
Injection
|
Ampoule |
1,000
|
109,725
|
109,725,000
|
N1 |
Batch release site: Ever Neuro Pharma GmbH
Batch release site: Austria
|
Nghe An
40018
|
2026-04-14 |
|
Cinnarizin
Cinnarizin
- Strength / route
- 25mg · Oral
- Qty
- 500 Tablet
- Total
- 40,000
- Group
- N4
- Manufacturer
- Khanh Hoa Pharmaceutical JSC (Vietnam)
- Province / Facility
- Ninh Binh · 37317
|
VD-31734-19 |
25mg
Oral
|
Tablet |
500
|
80
|
40,000
|
N4 |
Khanh Hoa Pharmaceutical JSC
Vietnam
|
Ninh Binh
37317
|
2026-04-14 |
|
Ciprobay 200
Ciprofloxacin
- Strength / route
- 200mg/100ml · Intravenous infusion
- Qty
- 17,851 Chai
- Total
- 3,466,235,776
- Group
- N1
- Manufacturer
- Bulk product manufacturing, primary and secondary packaging site: Fresenius Kabi Italia S.R.L; Batch release site: Bayer AG (Bulk product manufacturing, primary and secondary packaging site: Italy; Batch release site: Germany)
- Province / Facility
- Ho Chi Minh City · 79048
|
800115179623 |
200mg/100ml
Intravenous infusion
|
Chai |
17,851
|
194,176
|
3,466,235,776
|
N1 |
Bulk product manufacturing, primary and secondary packaging site: Fresenius Kabi Italia S.R.L; Batch release site: Bayer AG
Bulk product manufacturing, primary and secondary packaging site: Italy; Batch release site: Germany
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Ciprobay 400mg
Ciprofloxacin
- Strength / route
- 400mg/200ml · Intravenous infusion
- Qty
- 27,027 Chai
- Total
- 6,887,506,626
- Group
- N1
- Manufacturer
- Bulk product manufacturing, primary and secondary packaging site: Fresenius Kabi Italia S.R.L; Batch release site: Bayer AG (Bulk product manufacturing, primary and secondary packaging site: Italy; Batch release site: Germany)
- Province / Facility
- Ho Chi Minh City · 79048
|
800115179723 |
400mg/200ml
Intravenous infusion
|
Chai |
27,027
|
254,838
|
6,887,506,626
|
N1 |
Bulk product manufacturing, primary and secondary packaging site: Fresenius Kabi Italia S.R.L; Batch release site: Bayer AG
Bulk product manufacturing, primary and secondary packaging site: Italy; Batch release site: Germany
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Ciprobay 500
Ciprofloxacin
- Strength / route
- 500mg · Oral
- Qty
- 21,645 Tablet
- Total
- 286,233,480
- Group
- N1
- Manufacturer
- Bayer HealthCare Manufacturing S.r.l. (Italy)
- Province / Facility
- Ho Chi Minh City · 79048
|
800115179523 |
500mg
Oral
|
Tablet |
21,645
|
13,224
|
286,233,480
|
N1 |
Bayer HealthCare Manufacturing S.r.l.
Italy
|
Ho Chi Minh City
79048
|
2026-04-14 |
|
Cisplaton
Cisplatin
- Strength / route
- 50mg/100ml · Infusion
- Qty
- 2,876 Chai
- Total
- 519,405,600
- Group
- N2
- Manufacturer
- Venus Remedies Limited (India)
- Province / Facility
- Da Nang · 48126
|
890114086123 |
50mg/100ml
Infusion
|
Chai |
2,876
|
180,600
|
519,405,600
|
N2 |
Venus Remedies Limited
India
|
Da Nang
48126
|
2026-04-14 |
|
Claminat 1000mg/100mg
Amoxicilin + acid clavulanic
- Strength / route
- 1g + 0,1g · Injection
- Qty
- 7,000 Vial
- Total
- 264,600,000
- Group
- N2
- Manufacturer
- Imexpharm Corporation – Branch 3 in Binh Duong (Vietnam)
- Province / Facility
- Nghe An · 40018
|
893110271424 |
1g + 0,1g
Injection
|
Vial |
7,000
|
37,800
|
264,600,000
|
N2 |
Imexpharm Corporation – Branch 3 in Binh Duong
Vietnam
|
Nghe An
40018
|
2026-04-14 |
